Advances in Rheumatology
BioMed Central Ltd · United Kingdom · Est. 2018
✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.
See the official Impact Factor & quartile on the journal’s page ↗The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q2. Source: Clarivate Journal Citation Reports.
Aims & Scope
Advances in Rheumatology encompasses the full spectrum of adult and pediatric rheumatic diseases and related conditions. This Open Access journal provides a unique platform for pre-clinical, translational and clinical research, alongside review articles and society recommendations. We are the official publication of the Brazilian Society of Rheumatology, which covers members' article processing charges. Important notice: Please include the corresponding author’s ORCID iD in your manuscript file, as required for SciELO indexing. We recommend all co-authors include an ORCID iD, it is the responsibility of the submitting author to ensure ORCID iDs are included prior to publication. Please take note that as part of the editorial team (EiC, Editor, Editorial Board Member etc.) you would also need to state that in the Conflict of Interest section accordingly, please click here to find out more.
General Information
Submission Info
Ethics & Quality
Think.Check.Submit Compliance
Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.
Publication & Citation Trend
Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.
SJR Quartile by Discipline
Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.
Subject Classification
Web of Science Categories
Scopus Categories
Research Topics (OpenAlex)
Frequently asked questions about Advances in Rheumatology
Is Advances in Rheumatology a predatory journal?
PubScope has no integrity flags on record for Advances in Rheumatology: it is indexed in Web of Science, Scopus, DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 100/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.
What is the impact factor of Advances in Rheumatology?
Advances in Rheumatology is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 2.50.
Is Advances in Rheumatology indexed in Scopus and Web of Science?
Advances in Rheumatology is indexed in Web of Science, Scopus, DOAJ.
What is the aims and scope of Advances in Rheumatology?
Advances in Rheumatology encompasses the full spectrum of adult and pediatric rheumatic diseases and related conditions. This Open Access journal provides a unique platform for pre-clinical, translational and clinical research, alongside review articles and society recommendations. We are the official publication of the Brazilian Society of Rheumatology, which covers members' article processing charges. Important notice: Please include the corresponding author’s ORCID iD in your manuscript file, as required for SciELO indexing. We recommend all co-authors include an ORCID iD, it is the respons
You May Also Like
See all →Data updated: 2026-05-22 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref